Cardiovascular Autonomic Neuropathy and Early Atherosclerosis in Adolescent Type 1 Diabetic Patient
DOI:
https://doi.org/10.3889/oamjms.2015.131Keywords:
Cardiovascular autonomic neuropathy, coronary calcification, type 1 diabetic patientAbstract
AIM: To evaluate cardiovascular autonomic neuropathy (CAN) in type 1 Diabetics and to detect its relation to coronary artery calcification.
PATIENTS AND METHODS: It is a cross sectional study included 62 diabetics and 30 controls. Clinical, laboratory assessment and 24 Hr holter were done for all patients and controls and coronary artery calcium (CAC) scoring by multisclice CT was done for all patients only. T-test, Mann Whitney U test, and stepwise multiple regression were used for statistical analyses.
RESULTS: CAC score was positive in 8.1 % of patients. Heart rate variability (HRV) was significantly lower in diabetics. All parameters of HRV were insignificantly lower in diabetics with positive CAC score. Patients with microalbuminuria had a significantly lower HRV. HRV had a significant correlation with age of patients, duration of disease, HbA1, and Qtc in diabetics.
CONCLUSION: Percentage of arrhythmia and early atherosclerosis is high in adolescent type 1 diabetic patients. CAN is associated with early atherosclerosis. Cardiac autonomic neuropathy is associated with older age, longer duration, and poor glycemic control and microalbuminuria.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Retnakaran R, Zinman B. Type 1 diabetes, hyperglycaemia, and the heart. Lancet. 2008;371:1790–99.
http://dx.doi.org/10.1016/S0140-6736(08)60767-9 DOI: https://doi.org/10.1016/S0140-6736(08)60767-9
Airaksinem KEJ. Silent coronary artery disease in diabetes— a feature of autonomic neuropathy or accelerated atherosclerosis? Diabetologia. 2001; 44:259–66.
http://dx.doi.org/10.1007/s001250051609 DOI: https://doi.org/10.1007/s001250051609
PMid:11270686
Witte DR, Tesfaye S, Chaturvedi N, Eaton SE, Kempler P, Fuller JH, et al. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia. 2005;48:164–71.
http://dx.doi.org/10.1007/s00125-004-1617-y DOI: https://doi.org/10.1007/s00125-004-1617-y
PMid:15619072
Kempler P, Tesfaye S, Chaturvedi N, Stevens LK, Webb DJ, Eaton S, et al. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Diabet Med. 2002;19:900–09.
http://dx.doi.org/10.1046/j.1464-5491.2002.00821.x DOI: https://doi.org/10.1046/j.1464-5491.2002.00821.x
PMid:12421426
Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent disease. Eur Heart J. 2004;25:363–70.
http://dx.doi.org/10.1016/j.ehj.2003.12.003 DOI: https://doi.org/10.1016/j.ehj.2003.12.003
PMid:15033247
Schroeder EB, Liao D, Chambless LE, Prineas RJ, Evans GW, Heiss G. Hypertension, blood pressure, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) Study. Hypertension. 2003;42:1106–11.
http://dx.doi.org/10.1161/01.HYP.0000100444.71069.73 DOI: https://doi.org/10.1161/01.HYP.0000100444.71069.73
PMid:14581296
Rodrigues TC, Ehrlich J, Hunter CM, Kinney G L, Rewers M, and Snell-Bergeon JK. Reduced Heart Rate Variability Predicts Progression of Coronary Artery Calcification in Adults with Type 1 Diabetes and Controls Without Diabetes. Diabetes Technology and Therapeutics. 2010;12(12):963-69.
http://dx.doi.org/10.1089/dia.2010.0070 DOI: https://doi.org/10.1089/dia.2010.0070
PMid:21128843 PMCid:PMC3014754
Jyotsna VP, Abhay Sahoo A, Sreenivas V, Deepak KK. Prevalence and pattern of cardiac autonomic dysfunction in newly detected type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 2009;83:83-8.
http://dx.doi.org/10.1016/j.diabres.2008.09.054 DOI: https://doi.org/10.1016/j.diabres.2008.09.054
PMid:19042051
Gottsater A, Ryde´n-Ahlgren A, Szelag B, Hedblad B, Persson J, Berglund G, et al. Cardiovascular autonomic neuropathy associated with carotid atherosclerosis in type 2 diabetic patients. Diabet Med. 2003;20:495–99.
http://dx.doi.org/10.1046/j.1464-5491.2003.00956.x DOI: https://doi.org/10.1046/j.1464-5491.2003.00956.x
PMid:12786687
Gottsater A, Ahlgren AR, Taimour S, Sundkvist G. Decreased heart rate variability may predict the progression of carotid atherosclerosis in type 2 diabetes. Clin Auton Res. 2006;16:228–34.
http://dx.doi.org/10.1007/s10286-006-0345-4 DOI: https://doi.org/10.1007/s10286-006-0345-4
PMid:16763752
Raggi P, Callister TQ, Cooil B, He ZX, Lippolis NJ, Russo DJ, et al. Identification of patients at increased risk of unheralded acute myocardial infarction by electron-beam computed tomography. Circulation. 2000;101:850–55.
http://dx.doi.org/10.1161/01.CIR.101.8.850 DOI: https://doi.org/10.1161/01.CIR.101.8.850
PMid:10694523
Dabelea D, Kinney G, Snell-Bergeon JK, Hokanson JE, Eckel RH, Ehrlich J, et al. The Coronary Artery Calcification in Type 1 Diabetes Study; Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes. 2003;52:2833–39.
http://dx.doi.org/10.2337/diabetes.52.11.2833 DOI: https://doi.org/10.2337/diabetes.52.11.2833
PMid:14578303
Welch's PD. The Use of Fast Fourier Transform for the Estimation of Power Spectra: A Method Based on Time Averaging Over Short, Modified Periodograms. IEEE Transactions on Audio and Electroacoustics. 1967;15:70-73.
http://dx.doi.org/10.1109/TAU.1967.1161901 DOI: https://doi.org/10.1109/TAU.1967.1161901
Cowan MJ. Measurement of heart rate variability. Western Journal of Nursing Research. 1995;17(1):32–48;101–11.
http://dx.doi.org/10.1177/019394599501700104 DOI: https://doi.org/10.1177/019394599501700104
PMid:7863645
Faulkner MS, Quinn L and Fritschi C. Microalbuminuria and Heart Rate Variability in Adolescents with Diabetes. J Pediatr Health Care. 2010;24(1):34-47.
http://dx.doi.org/10.1016/j.pedhc.2009.01.002 DOI: https://doi.org/10.1016/j.pedhc.2009.01.002
PMid:20122476 PMCid:PMC2819478
Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. American Journal of Cardiology. 1987;59(4):256–62.
http://dx.doi.org/10.1016/0002-9149(87)90795-8 DOI: https://doi.org/10.1016/0002-9149(87)90795-8
Kleiger RE, Stein PK, Bosner MS, Rottman JN. Time domain measurements of heart rate variability. Cardiol Clin. 1992;10:487-98. DOI: https://doi.org/10.1016/S0733-8651(18)30230-3
PMid:1504980
Bazett, HC. An analysis of the time relationships of the electrocardiograms. Heart. 1920;7:353–57.
Yaghoubi S, Tang W, Wang S, Reed J, Hsiai J , Detrano R, et al. Offline assessment of atherosclerotic coronary calcium from electron beam tomograms. Am J Card Imaging. 1995;9(4):231-36.
Boysen A, Lewin MA, Hecker W, Leichter HE, Uhlemann F. Autonomic function testing in children and adolescents with diabetes mellitus. Pediatric Diabetes. 2007;8(5):261–64.
http://dx.doi.org/10.1111/j.1399-5448.2007.00254.x DOI: https://doi.org/10.1111/j.1399-5448.2007.00254.x
PMid:17850468
Faulkner MS, Hathaway DK, Milstead EJ, Burghen GA. Heart rate variability in adolescents and adults with T1DM. Nursing Research. 2001;50(2):95–104.
http://dx.doi.org/10.1097/00006199-200103000-00005 DOI: https://doi.org/10.1097/00006199-200103000-00005
PMid:11302298
Faulkner MS, Quinn L, Rimmer JH, Rich BH. Cardiovascular endurance and heart rate variability in adolescents with type 1 or type 2 diabetes. Biological Research for Nursing. 2005;7(1):16–29.
http://dx.doi.org/10.1177/1099800405275202 DOI: https://doi.org/10.1177/1099800405275202
PMid:15920000 PMCid:PMC1447599
Chen H, Wu T, Jap T, Lee S, Wang M, Lu R, et al. Decrease heart rate variability but preserve postural blood pressure change in type 2 diabetes with microalbuminuria. J Clin Med Assoc. 2006;69(6):254–58.
http://dx.doi.org/10.1016/S1726-4901(09)70252-7 DOI: https://doi.org/10.1016/S1726-4901(09)70252-7
Gandhi RA, Marques JL, Selvarajah D, Emary C, Tesfaye S. Painful diabetic neuropathy is associated with greater autonomic dysfunction than painless diabetic neuropathy. Diabetes Care. 2010;33(7):1585–90.
http://dx.doi.org/10.2337/dc09-2314 DOI: https://doi.org/10.2337/dc09-2314
PMid:20587724 PMCid:PMC2890363
Maser RE, Pfeifer MA, Dorman JS, Kuller LH, Becker DJ, Orchard TJ. Diabetic autonomic neuropathy and cardiovascular risk. Epidemiology of Diabetes Complications Study III. Arch Intern Med. 1990;150:1218–22.
http://dx.doi.org/10.1001/archinte.1990.00390180056009 DOI: https://doi.org/10.1001/archinte.1990.00390180056009
PMid:2353855
Toyry JP, Niskanen LK, Mantysaari MJ, Lansimies EA, Uusitupa MIJ. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten year follow-up from the diagnosis. Diabetes. 1996;45:308-15. DOI: https://doi.org/10.2337/diabetes.45.3.308
http://dx.doi.org/10.2337/diab.45.3.308 DOI: https://doi.org/10.2337/diab.45.3.308
PMid:8593935
Salem M, Moneir I, Adly AM and Esmat K. Study of coronary artery calcification risk in Egyptian adolescents with type 1 diabetes. Acta Diabetol. 2011;48:41-53.
http://dx.doi.org/10.1007/s00592-010-0214-4 DOI: https://doi.org/10.1007/s00592-010-0214-4
PMid:20706852
Kacem K, Bonvento G, Seylaz J. Effect of sympathectomy on the phenotype of smooth muscle cells of middle cerebral and ear arteries of hyperlipidaemic rabbits. Histochem J. 1997;29:279–86.
http://dx.doi.org/10.1023/A:1026418413313 DOI: https://doi.org/10.1023/A:1026418413313
PMid:9184842
Sarmento A, Soares-da-Silva P, Teixeira AA, Azevedo I. Effects of denervation induced by 6-hydroxydopamine on cell nucleus activity of arterial and cardiac cells of the dog. J Auton Pharmacol. 1987;17:119–26.
http://dx.doi.org/10.1111/j.1474-8673.1987.tb00141.x DOI: https://doi.org/10.1111/j.1474-8673.1987.tb00141.x
Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405:458–62.
http://dx.doi.org/10.1038/35013070 DOI: https://doi.org/10.1038/35013070
PMid:10839541
Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003;421:384–88.
http://dx.doi.org/10.1038/nature01339 DOI: https://doi.org/10.1038/nature01339
PMid:12508119
Bigger JT. Spectral analysis of R-R variability to evaluate autonomic physiology and pharmacology and to predict cardiovascular outcomes in humans, in: D.P. Zipes, J. Jalife (Eds.), Cardiac Electrophysiology from Cell to Bedside, second ed., WB Saunders Company, Philadelphia, PA, 1995: 1151- 70.
Lown B, Verrier RL. Neural activity and ventricular fibrillation, New Engl J Med. 1976;294:1165-70.
http://dx.doi.org/10.1056/NEJM197605202942107 DOI: https://doi.org/10.1056/NEJM197605202942107
PMid:57572
Corr PB, Yamada KA, Witkowski FX. Mechanisms controlling cardiac autonomic function and their relation to arrhythmogenesis, in: H.A. Fozzard, E. Haber, R.B. Jennings (Eds.), The Heart and Cardiovascular System, Raven Press, New York, NY, 1986:1343-1403.
Wheeler SG, Jessie H. Ahroni JH, Boyko EJ. Prospective study of autonomic neuropathy as a predictor of mortality in patients with diabetes. Diabetes Research and Clinical Practice. 2002;58:131-38.
http://dx.doi.org/10.1016/S0168-8227(02)00128-6 DOI: https://doi.org/10.1016/S0168-8227(02)00128-6
Smulders YM, Jager A, Gerritsen J, Dekker JM, Nijpels G, Heine RJ, et al. Cardiovascular autonomic function is associated with (micro-) albuminuria in elderly Caucasian subjects with impaired glucose tolerance or type 2 diabetes. Diabetes Care. 2000;23:1369–74.
http://dx.doi.org/10.2337/diacare.23.9.1369 DOI: https://doi.org/10.2337/diacare.23.9.1369
PMid:10977035
Zander E, Schulz B, Heinke P, Grimmberger E, Zander G, Gottschling HD. Importance of cardiovascular autonomic dysfunction in IDDM subjects with diabetic nephropathy. Diabetes Care. 1989;12(4):259–64.
http://dx.doi.org/10.2337/diacare.12.4.259 DOI: https://doi.org/10.2337/diacare.12.4.259
PMid:2707113
Burger A J, Hamer AW, Weinrauch LA, D'Elia JA. Relation of heart rate variability and serum lipoproteins in Type 1 diabetes mellitus and chronic Stable angina pectoris. Am J Cardiol. 1998;81:945–49.
http://dx.doi.org/10.1016/S0002-9149(98)00070-8 DOI: https://doi.org/10.1016/S0002-9149(98)00070-8
Chessa M, Butera G, Lanza GA, Bossone E, Delogu A, De Rosa G, et al. Role of heart rate variability in the early diagnosis of diabetic autonomic neuropathy in children. Herz. 2002;27:785–90.
http://dx.doi.org/10.1007/s00059-002-2340-4 DOI: https://doi.org/10.1007/s00059-002-2340-4
PMid:12574897
Colhoun HM, Francis DP, Rubens MB, Underwood SR, Fuller JH. The association of heart-rate variability with cardiovascular risk factors and coronary artery calcification: a study in type 1 diabetic patients and the general population. Diabetes Care. 2001;24:1108–14.
http://dx.doi.org/10.2337/diacare.24.6.1108 DOI: https://doi.org/10.2337/diacare.24.6.1108
PMid:11375379
Chen S, Lee Y, Chiu H, Jeng C. Impact of Glycemic Control, Disease Duration, and Exercise on Heart Rate Variability in Children with Type 1 Diabetes Mellitus. J Formos Med Assoc. 2007;106(11):935–42.
http://dx.doi.org/10.1016/S0929-6646(08)60064-9 DOI: https://doi.org/10.1016/S0929-6646(08)60064-9
Lanjewar P, Pathak V, Lokhandwala Y. Issues in QT interval measurement. Indian Pacing Electrophysiol J. 2004;4(4):156-61.
PMid:16943929 PMCid:PMC1502066
Fiorentini A, Perciaccante A, Valente R, Paris A, Serra P, Tubani L. The correlation among QTc interval, hyperglycaemia and the impaired autonomic activity. Autonomic Neuroscience: Basic and Clinical. 2010;154:94–98.
http://dx.doi.org/10.1016/j.autneu.2009.11.006 DOI: https://doi.org/10.1016/j.autneu.2009.11.006
PMid:19963442
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0